Home
My Account
About Us
Forum
Contact us
الواجهة العربية
epharmaweb.com
Medical News Medical News
Aricles Articles
Events Events
Guidelines Guidelines
Videos Library Videos Library
Diseases Diseases
Follow us : facebook twitter Digg Linkedin Boxiz
Newsletter

Please select the categories you are intersted in:
News Articles Guidelines Events Videos Journals' abstracts

Latest Subscribers
Advanced Search »

Histadestal

Main

You must sign in to use this servcie


Feedback - Please use the form below to send your query or comment

You must sign in to use this servcie

Username:
Password:

Info

Indications:

a basic treatment for allergic conditions and not a remedy for acute symptoms. It is therefore recommended for all allergic complaints whatever their symptoms or causes. (a) Respiratory: bronchial asthma, asthmatic bronchitis, chronic bronchitis, spasmodic tracheitis, hay fever, allergic rhinitis. (b) Cutaneous: eczema, urticaria, generalised skin allergies. (c) Nervous: migraine. (d) Gynaecological: premenstrual syndrome when of allergic aetiology. (e) may be used prophylactically with children (where there is a family history of allergy) who are about to undergo an adenoidectomy or tonsillectomy

Contraindications:

It is advisable to avoid treatment during pregnancy or during menstruation. Do not administer during an acute allergic attack.

Adverse reactions:

normally well tolerated even by children and infants, however, in very rare cases an exacerbation of the clinical symptoms is observed after the 1st and 2nd injection. This is only of a transient nature and is usually a sign that the system is responding favourably to the medication. It can be alleviated by the usual symptomatic treatment. Injections must always be given subcutaneously.

Interactions:

Warnings:

Use a cold syringe, Always treat any existing superinfection before beginning treatment. Never start treatment during an acute allergic attack, specially an acute asthmatic attack. In such cases the usual specific remedy must be used first. Should an acute attack occur after an injection of treatment, this should be viewed as a positive sign. Discontinue treatment until symptomatic treatment has alleviated the acute attack, and then continue the regime. In small doses, corticoid therapy is compatible with treatment. In many cases the doses of corticoids can be gradually reduced, or even stopped. not contra-indicated with desensitization treatment. In a good number of cases a combined treatment appears to reinforce the effects. It is important to remember that results may only be evident 3 to 4 weeks after the end of treatment. The duration of protection may vary from patient to patient and may last from several months to several years. The physician should establish the appropriate intervals for the booster injection according to patient results.

Form:

SOLUTION FOR INJECTION

Dosage and Administration

You must sign in to use this servcie

Technical Description

You must sign in to use this servcie





Forgot your password


sign up
Consultants Corner

Dr. Faisal Dibsi

Dr. Faisal Dibsi Specialist of Otolaryngology - Head and Neck Surgery

Samir Moussa M.D.

Samir Moussa M.D. ENT Specialist

Yaser Habrawi , F.R.C.S.Ed

Yaser Habrawi , F.R.C.S.Ed Consultant Ophthalmologist

Dr . Dirar Abboud

Dr . Dirar Abboud Hepatologist – Gastroenterologist

Dr. Tahsin Martini

Dr. Tahsin Martini Degree status: M.D. in Ophthalmology

Dr. Talal Sabouni

Dr. Talal Sabouni UROLOGY AND KIDNEY TRANSPLANT

Dr. Hani Najjar

Dr. Hani Najjar Pediatrics, Neurology

Dr. Samer Al-Jneidy

Dr. Samer Al-Jneidy Pediatrician

Poll

Disclaimer : This site does not endorse or recommend any medical treatment, pharmaceuticals or brand names. More Details